Botulism type B presenting as pure autonomic dysfunction

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Clinical Autonomic Research

• Publication date

  2003-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s10286-003-0118-2PMID 14564656
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group, double blind, placebo controlled trial

  2001cited by this paper
• Injections of botulinum toxin A into the salivary glands improve sialorrhoea in amyotrophic lateral sclerosis

  2000cited by this paper
• Erectile dysfunction.

  2000cited by this paper
• Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia.

  1999cited by this paper
• Botulinum toxin in the treatment of neurological disorders of the autonomic nervous system.

  1999cited by this paper
• Autonomic dysfunction in botulism B

  1975cited by this paper
• Type B botulism in man.

  1967cited by this paper

• Advances in Clostridial Neurotoxins: Passage of the Intestinal Barrier and Targeting of Specific Neuronal Cells

  2026cites this paper
• Autonomic Dysfunction and Blood Pressure Variability in Botulinum Intoxication: A Prospective Observational Study from a Single-Center Italian Outbreak

  2025cites this paper
• Foodborne Botulism Presenting With Isolated Cranial Nerve Involvement in a Young Adult

  2025cites this paper
• Introduction to the Physiology, Anatomy, and Biochemistry of Autonomic Medicine.

  2025cites this paper
• Review on Foodborne Botulism: Historical Notes, Diagnosis and Treatment

  2024cites this paper
• Botulism

  2024cites this paper
• Clinical Guidelines for Diagnosis and Treatment of Botulism, 2021

  2021cites this paper
• Characterization of cardiac autonomic function in COVID-19 using heart rate variability: a hospital based preliminary observational study

  2021cites this paper
• Infections of the Peripheral Nervous System

  2021cites this paper
• Transient Receptor Potential Vanilloid Subtype 1: Potential Role in Infection, Susceptibility, Symptoms and Treatment of COVID-19

  2021cites this paper
• Toxemia in Human Naturally Acquired Botulism

  2020cites this paper
• Botulism outbreak after the consumption of vegetarian pâté in the south of Viet Nam

  2020cites this paper
• Neuronal selectivity of botulinum neurotoxins.

  2018cites this paper
• Foodborne botulism due to ingestion of home-canned green beans: two case reports

  2018cites this paper
• Infectious diseases causing autonomic dysfunction

  2018cites this paper
• Autonomic dysfunction in the neurological intensive care unit

  2018cites this paper
• Uptake of Clostridial Neurotoxins into Cells and Dissemination.

  2017cites this paper
• Botulinum neurotoxin type B uses a distinct entry pathway mediated by CDC42 into intestinal cells versus neuronal cells

  2017cites this paper
• Foodborne pathogens

  2017cites this paper
• Clostridium botulinum and the Most Poisonous Poison

  2017cites this paper
• Diversity of Group I and II Clostridium botulinum Strains from France Including Recently Identified Subtypes

  2016cites this paper
• Autonomic Neuropathy

  2015cites this paper
• Botulinum Neurotoxins: Qualitative and Quantitative Analysis Using the Mouse Phrenic Nerve Hemidiaphragm Assay (MPN)

  2015influential citation
• Chapter 43 – Botulism

  2014cites this paper
• Prevention and Treatment of Botulism

  2014cites this paper
• Long lasting dysautonomia due to botulinum toxin B poisoning: clinical- laboratory follow up and difficulties in initial diagnosis

  2013cites this paper
• Wide range of clinicopathological features in immune‐mediated autonomic neuropathies

  2013cites this paper
• Botulinum toxin A versus B in sialorrhea: A prospective, randomized, double‐blind, crossover pilot study in patients with amyotrophic lateral sclerosis or Parkinson's disease

  2011cites this paper
• Botulinum Toxin Type B in the Treatment of Residual Limb Hyperhidrosis for Lower Limb Amputees: A Pilot Study

  2011cites this paper
• 5 – Autonomic Dysfunction in Neuromuscular Disorders

  2010cites this paper
• Infant botulism intoxication and autonomic nervous system dysfunction.

  2009cites this paper
• The Nervous System as a Target for Chemical Warfare Agents

  2009cites this paper
• BOTULIZMAS: LITERATŪROS APŽVALGA BOTULISM: REVIEW OF LITERATURE

  2009influential citation
• An outbreak of foodborne botulism in Taiwan.

  2009cites this paper
• Quantitative autonomic testing in the management of botulism

  2009cites this paper
• CLINIQUE andysautonomie aiguë lentement régressive ssociée à une achalasie de l ’ œsophage : propos d ’ un cas lowly regressing acute pandysautonomia associated ith esophageal achalasia : A case report

  2008cites this paper
• Pandysautonomie aiguë lentement régressive associée à une achalasie de l’œsophage : à propos d’un cas

  2008cites this paper
• Engineered toxins: new therapeutics.

  2008cites this paper
• Mechanism of action of botulinum neurotoxin and overview of medical countermeasures for intoxication.

  2008cites this paper
• [Slowly regressing acute pandysautonomia associated with esophageal achalasia: a case report].

  2008cites this paper
• CHAPTER 46 – Botulism

  2007cites this paper
• Autonomic peripheral neuropathy.

  2007cites this paper
• PERIPHERAL AUTONOMIC NEUROPATHIES

  2007cites this paper
• Biphasic botulism diagnosed by electromyogram

  2006cites this paper
• Autonomic peripheral neuropathy.

  2005cites this paper
• Botulinum toxin A (Botox) and sweating-dose efficacy and comparison to other BoNT preparations.

  2005cites this paper
• [Effect of botulinum toxin a and B on vegetative cardiac innervation].

  2005cites this paper
• Medical aspects of toxin weapons.

  2005cites this paper
• Botulinum Toxins – Cause of Botulism and Systemic Diseases?

  2005cites this paper
• Autonomic function after botulinum toxin type A or B: A double-blind, randomized trial

  2005cites this paper
• A case of oligosymptomatic botulism. The role of single‐fiber EMG in early diagnosis

  2004cites this paper
• Die Wirkung von Botulinumtoxin A und B auf die vegetative kardiale Innervation

  2004cites this paper